ORION
5 known investors
Find your way into ORION
Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
Founders & leadership
GP
Guillaume ParéFounder & President
Investors · 5
Also in the syndicate · 3
IBMLama PartnersNorwestlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2026
Norwest (lead), IBM, Lama Partners, PICO Venture Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ORION do?
- Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
- Who founded ORION?
- ORION was founded by Guillaume Paré.
- Who are ORION's investors?
- ORION's investors include CABHI Ventures, PICO Venture Partners.